O'Brien M - Search Results

1

Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non-Small-Cell Lung Cancer: A Real-World Study.

Kobat H, Elkonaissi I, Foreman E, Davidson M, Idaikkadar P, O'Brien M, Nabhani-Gebara S. Kobat H, et al. Clin Lung Cancer. 2024 Jan;25(1):e35-e42. doi: 10.1016/j.cllc.2023.09.007. Epub 2023 Oct 4. Clin Lung Cancer. 2024. PMID: 37880075 Free article.

2

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.

de Boer RH, Smith IE, Pastorino U, O'Brien ME, Ramage F, Ashley S, Goldstraw P. de Boer RH, et al. Br J Cancer. 1999 Mar;79(9-10):1514-8. doi: 10.1038/sj.bjc.6690241. Br J Cancer. 1999. PMID: 10188899 Free PMC article. Clinical Trial.

3

The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer.

Banerji U, Ashley S, Coward J, Hughes S, Zee Y, Benepal T, Norton A, Eisen T, O'Brien M. Banerji U, et al. Lung Cancer. 2006 Dec;54(3):371-7. doi: 10.1016/j.lungcan.2006.08.001. Epub 2006 Oct 17. Lung Cancer. 2006. PMID: 17049670

4

Recurrent responses to non-small cell lung cancer brain metastases with erlotinib.

Popat S, Hughes S, Papadopoulos P, Wilkins A, Moore S, Priest K, Meehan L, Norton A, O'Brien M. Popat S, et al. Lung Cancer. 2007 Apr;56(1):135-7. doi: 10.1016/j.lungcan.2006.11.009. Epub 2006 Dec 8. Lung Cancer. 2007. PMID: 17157952

5

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival.

Sirohi B, Ashley S, Norton A, Popat S, Hughes S, Papadopoulos P, Priest K, O'Brien M. Sirohi B, et al. J Thorac Oncol. 2007 Aug;2(8):735-40. doi: 10.1097/JTO.0b013e31811f3a7d. J Thorac Oncol. 2007. PMID: 17762340 Free article.

6

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer.

Popat S, Barbachano Y, Ashley S, Norton A, O'Brien M. Popat S, et al. Lung Cancer. 2008 Feb;59(2):227-31. doi: 10.1016/j.lungcan.2007.08.027. Epub 2007 Oct 24. Lung Cancer. 2008. PMID: 17920156

7

Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.

O'Brien ME, Socinski MA, Popovich AY, Bondarenko IN, Tomova A, Bilynsky BT, Hotko YS, Ganul VL, Kostinsky IY, Eisenfeld AJ, Sandalic L, Oldham FB, Bandstra B, Sandler AB, Singer JW. O'Brien ME, et al. J Thorac Oncol. 2008 Jul;3(7):728-34. doi: 10.1097/JTO.0b013e31817c6b68. J Thorac Oncol. 2008. PMID: 18594318 Free article. Clinical Trial.

8

The combination of Young's syndrome and small cell lung cancer-A spiky connection?

Forster M, Enting D, Nicholson AG, O'Brien M, Popat S. Forster M, et al. Lung Cancer. 2010 Mar;67(3):372-5. doi: 10.1016/j.lungcan.2009.10.011. Epub 2009 Dec 1. Lung Cancer. 2010. PMID: 19954857

9

Treatment options for small cell lung cancer - do we have more choice?

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME. Puglisi M, et al. Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.

10

Modest reductions in dose intensity and drug-induced neutropenia have no major impact on survival of patients with non-small cell lung cancer treated with platinum-doublet chemotherapy.

Brunetto AT, Carden CP, Myerson J, Faria AL, Ashley S, Popat S, O'Brien ME. Brunetto AT, et al. J Thorac Oncol. 2010 Sep;5(9):1397-403. doi: 10.1097/JTO.0b013e3181eba7f9. J Thorac Oncol. 2010. PMID: 20644495 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,327 results

Search Page